Skip to main content

Table 2 Association of DAX-1 with various clinicopathological factors and with estrogen receptor-α, estrogen receptor-β and androgen receptor status

From: DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status

Parameter n Negative Nuclear location P Cytoplasmic location P
Age (years)       
   ≤50 11 5 4   2  
   >50 28 9 11 0.699 8 0.652
TNM class       
   T1 19 10 7   2  
   T2 16 6 6   4  
   T3 2 1 1   0  
   T4 2 0 0 0.8486 2 0.216
Nodal status (%)       
   ≤33 26 14 6   6  
   33–90 10 2 7   1  
   >90 3 0 1 <0.05 2 0.1439
Histological type       
   Ductal 24 10 9   5  
   Lobular 15 4 6 0.699 5 0.4028
Disease-free duration (months)       
   5–20 3 0 1   2  
   20–30 10 2 5   3  
   >30 26 11 9 0.3081 6 0.1713
ER-α       
   - 10 5 3   2  
   C 9 2 2   5  
   N 20 7 10 0.6077 3 0.1649
ER-β       
   - 23 9 7   7  
   C 13 5 6   3  
   N 3 1 2 0.7138 0 0.6766
AR       
   - 20 12 6   2  
   C 17 2 7   8  
   N 2 0 2 <0.05 0 <0.001
  1. AR, androgen receptor; ER, estrogen receptor. C, cytoplasmic immunoreaction; N, nuclear immunostaining.
\